Related Experiment Video

Updated: May 14, 2026

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
08:47

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells

Published on: May 1, 2020

Phosphorylation of 4E-BP1 predicts sensitivity to everolimus in gastric cancer cells

Tetsuo Nishi1, Kenta Iwasaki, Norifumi Ohashi

  • 1Nagoya University Graduate School of Medicine, Department of Gastroenterological Surgery (Surgery II), Nagoya 466-8550, Japan. ntetsu@med.nagoya-u.ac.jp

Cancer Letters
|January 24, 2013
PubMed

Insights

Everolimus effectively inhibited gastric cancer cell proliferation in sensitive cell lines. High 4E-BP1 phosphorylation levels predict response to everolimus treatment in gastric cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Gastric cancer remains a significant global health challenge.
  • Targeted therapies, including mTOR inhibitors like everolimus, offer potential treatment avenues.
  • Identifying predictive biomarkers is crucial for optimizing patient selection and treatment efficacy.

Purpose of the Study:

  • To investigate the efficacy of everolimus in human gastric cancer cell lines.
  • To explore the role of 4E-BP1 phosphorylation as a potential biomarker for everolimus sensitivity.
  • To correlate 4E-BP1 phosphorylation status with treatment response in preclinical models.

Main Methods:

  • Treatment of human gastric cancer cell lines with everolimus.
  • Assessment of cell proliferation inhibition.
  • Analysis of basal and treatment-induced 4E-BP1 phosphorylation (T37/46, T70) via Western blotting or similar techniques.
  • Evaluation in a subcutaneous xenograft mouse model using immunohistochemistry.

Main Results:

  • Everolimus demonstrated significant inhibition of cell proliferation in 3 out of 8 gastric cancer cell lines.
  • Everolimus-sensitive cell lines exhibited higher basal phosphorylation levels of 4E-BP1 (T37/46, T70) compared to resistant lines.
  • Immunohistochemistry in xenograft models confirmed high phospho-4E-BP1 (T37/46) expression in everolimus-sensitive cells.

Conclusions:

  • Phosphorylation of 4E-BP1 serves as a potential predictive biomarker for everolimus sensitivity in gastric cancer.
  • This finding could aid in selecting patients most likely to benefit from everolimus therapy.
  • Further clinical validation is warranted to confirm the utility of phospho-4E-BP1 as a biomarker.

More Related Videos

Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase09:51

Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase

Published on: June 30, 2023

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...